{{Rsnum
|rsid=706779
|Gene=IL2RA
|Chromosome=10
|position=6098824
|Orientation=minus
|GMAF=0.4711
|Assembly=GRCh37
|GenomeBuild=37.1
|dbSNPBuild=131
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
}}
{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 31.5 | 45.0 | 23.4
| HCB | 40.4 | 50.0 | 9.6
| JPT | 32.7 | 46.9 | 20.4
| YRI | 26.5 | 49.0 | 24.5
| ASW | 19.3 | 57.9 | 22.8
| CHB | 40.4 | 50.0 | 9.6
| CHD | 32.1 | 53.2 | 14.7
| GIH | 34.7 | 47.5 | 17.8
| LWK | 29.1 | 50.0 | 20.9
| MEX | 6.9 | 50.0 | 43.1
| MKK | 25.0 | 46.8 | 28.2
| TSI | 17.6 | 50.0 | 32.4
| HapMapRevision=28
}}{{PMID Auto GWAS
|PMID=20410501
|Trait=Vitiligo
|Title=Variant of TYR and Autoimmunity Susceptibility Loci in Generalized Vitiligo
|RiskAllele=A
|Pval=3E-9
|OR=1.27
|ORtxt=[1.17-1.37]
|OA=1
}}

{{PMID Auto
|PMID=18840781
|Title=Follow-up analysis of genome-wide association data identifies novel loci for type 1 diabetes.
|OA=1
}}

{{PMID Auto
|PMID=19956101
|Title=Overview of the Rapid Response data.
|OA=1
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Illumina Human 1M}}